NCT05637398View on ClinicalTrials.gov

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

November 1, 2025

Conditions
HFpEF - Heart Failure With Preserved Ejection FractionColchicine
Interventions
DRUG

Colchicine

The active treatment intervention consists of colchicine 0.5 mg twice daily that will be administrated by the investigator

Trial Locations (2)

119415

RECRUITING

A Shchendrygina, Moscow

RECRUITING

Anastasia Shchendrygina, Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER